In an AD mouse model featuring APP/PS1 mice, liraglutide prevented memory impairments in object recognition and water maze tasks and prevented synapse loss and the deterioration of synaptic plasticity in the hippocampus [215]. The gene discussed is APP; the disease is Alzheimer disease.